ERRATUM: Systematic Review and Meta-Analysis of the Efficacy and Safety of Amfepramone and Mazindol As a Monotherapy for the Treatment of Obese or Overweight Patients. Clinics 2018, 73, e1err. https://doi.org/10.6061/clinics/2018/e1err.